InvestorsHub Logo
icon url

biomaven0

09/27/11 10:39 AM

#127413 RE: pcrutch #127406

PolyMedix Initiates Phase 1B/2 Dose-Response Clinical Trial to Reverse the Anticoagulant Activity of Enoxaparin with PMX-60056



The trial they should have run the first time round...